Acral Fibromyxoma with loss of Rb1 by immunohistochemistry and Fluorescence In Situ Hybridization: A diagnostically exploitable marker.

Acral fibromyxoma (AF) is a slow growing benign soft tissue tumor with predilection to subungal and periungal region of the hands or feet. CD34 expression is consistently expressed whereas very recently loss of Rb1 expression was described as a possible driver molecular event for this entity. Herein we present two additional cases of AF with loss of Rb1 expression by IHC and subsequent confirmation of loss of the RB1 gene locus by fluorescence in situ hybridization (FISH). We hope to raise awareness in dermatopathology community of this new discovery, which can be diagnostically exploitable for this distinct and likely underreported neoplasm. This article is protected by copyright. All rights reserved.